Log in
Enquire now
BridgeBio

BridgeBio

BridgeBio is a San Francisco-based biotechnology researching and producing genetically-targeted therapeutics.

OverviewStructured DataIssuesContributors

Contents

bridgebio.com
bridgebiollc.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Immunotherapy
Immunotherapy
Genealogy
Genealogy
Genetics
Genetics
Pharmaceutical industry
Pharmaceutical industry
Biomedical engineering
Biomedical engineering
Enzyme kinetics
Enzyme kinetics
...
Location
United States
United States
San Francisco
San Francisco
0
North Carolina
North Carolina
Palo Alto, California
Palo Alto, California
B2X
B2B
B2B
CEO
Neil Kumar
Neil Kumar
0
Founder
Neil Kumar
Neil Kumar
Frank McCormick
Frank McCormick
AngelList URL
angel.co/company/bridgebio
Pitchbook URL
pitchbook.com/profiles...165914-74
Legal Name
BridgeBio Pharma, Inc.
Subsidiary
‌
Navire Pharma
Qed Therapeutics
Qed Therapeutics
0
‌
Eidos Therapeutics
Legal classification
Corporation
Corporation
Incorporation (business)
Incorporation (business)
Number of Employees (Ranges)
51 – 200
Email Address
info@bridgebio.com
Phone Number
+16503919740
Full Address
421 Kipling St, Palo Alto, California US
CIK Number
1,743,8810
Place of Incorporation
Delaware
Delaware
0
Investors
Janus Henderson Investors
Janus Henderson Investors
Hercules Capital
Hercules Capital
Perceptive Advisors
Perceptive Advisors
Cormorant Capital
Cormorant Capital
‌
Kohlberg Ventures
KKR
KKR
Sequoia Capital
Sequoia Capital
Viking Global Investors
Viking Global Investors
...
DUNS Number
1171096440
Founded Date
January 1, 2014
Total Funding Amount (USD)
1,633,200,000
Latest Funding Round Date
January 2021
Competitors
MyoKardia
MyoKardia
Aimmune Therapeutics
Aimmune Therapeutics
Magenta Therapeutics
Magenta Therapeutics
Mirati Therapeutics
Mirati Therapeutics
vTv Therapeutics
vTv Therapeutics
Kadmon
Kadmon
Quest PharmaTech
Quest PharmaTech
Syros Pharmaceuticals
Syros Pharmaceuticals
Business Model
Commerce
Stock Symbol
BBIO0
Exchange
Nasdaq
Nasdaq
0
Board of Directors
Andrew Lo
Andrew Lo
0
‌
Richard Scheller
0
Brenton L. Saunders
Brenton L. Saunders
0
Neil Kumar
Neil Kumar
0
Hannah Valantine
Hannah Valantine
0
‌
Douglas Dachille
0
Randy Scott
Randy Scott
0
Jennifer Cook
Jennifer Cook
0
...
Latest Funding Type
Series D
Series D
NAICS Code
325,4120
CAGE Code
8FVJ90
Motto/Tagline
Hope Through Rigorous Science
Wellfound ID
bridgebio
Country
United States
United States

Other attributes

Company Operating Status
Active
Invested in
MyoKardia
MyoKardia
Latest Funding Round Amount (USD)
250,000,000
Previous Name
BridgeBio Pharma LLC0
SIC Code
2,8340
Ticker Symbol
BBIO

BridgeBio Pharma Inc is involved in identifying medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. BridgeBio builds out subsidiary companies around different inherited genetic diseases. The company seeks to translate scientific discoveries from universities, academic medical centers, and pharmaceutical research groups into genetically-targeted therapeutics to address the fundamental causes of diseases. The companies portfolio assets span therapeutic areas, including:

  • Genetic dermatology
  • Oncology
  • Cardiology
  • Neurology
  • Endocrinology
  • Renal disease
  • Ophthalmology

Some of the specific indications BridgeBio targets include transthyretin amyloidosis (ATTR-CM and ATTR-PN), pantothenate kinase-associated neurodegeneration, Gorlin syndrome and frequent basal cell carcinomas, dystrophic epidermolysis bullosa, Darier and Hailey-Hailey diseases, Netherton syndrome, venous malformations, Canavan disease, Leber's hereditary optic neuropathy, molybdenum cofactor deficiency Type A, achondroplasia, and FGFR, SHP-2, and K-RAS-drive cancers.

Partners

BridgeBio's partners include Leo Pharma, Leidos, Novartis, Cincinnati Children's, Boston Children's Hospital, Takeda, Infinity Pharmaceuticals, NeuroVive Pharmaceutical, St. Jude Children's Research Center, The University of Texas MD Anderson Cancer Center, Spark at Stanford, and University of California San Francisco.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like BridgeBio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.